- Advertisement -
Melbourne-headquartered life sciences venture capital firm Brandon Capital has raised $439 million to invest in both early and late-stage Australian medical science companies, including $150 million from the National Reconstruction Fund Corporation (NRFC).
The news comes after Brandon Capital…
Click here to view the original article.
